These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29275924)

  • 21. Complications with the use of botulinum toxin.
    Klein AW
    Dermatol Clin; 2004 Apr; 22(2):197-205, vii. PubMed ID: 15222580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature.
    Gioltzoglou T; Cordivari C; Lee PJ; Hanna MG; Lees AJ
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1594-6. PubMed ID: 16227561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity.
    Goldstein EM
    J Child Neurol; 2006 Mar; 21(3):189-92. PubMed ID: 16901418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications and adverse reactions with the use of botulinum toxin.
    Klein AW
    Dis Mon; 2002 May; 48(5):336-56. PubMed ID: 12195264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Adverse events following repeated injections with botulinum toxin A in children with spasticity'.
    Mohamed KA; Moore AP; Rosenbloom L
    Dev Med Child Neurol; 2001 Nov; 43(11):791. PubMed ID: 11730154
    [No Abstract]   [Full Text] [Related]  

  • 26. A cause of reversible dysphagia: an unusual presentation of myasthenia gravis.
    Brostoff JM; Dahdaleh D; Birns J
    Eur J Intern Med; 2008 Jan; 19(1):70. PubMed ID: 18206608
    [No Abstract]   [Full Text] [Related]  

  • 27. Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy.
    Naidu K; Smith K; Sheedy M; Adair B; Yu X; Graham HK
    Dev Med Child Neurol; 2010 Feb; 52(2):139-44. PubMed ID: 20412252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new facial expression to botox!
    Aggarwal A; Kaul V; Kaur G; Banas E; Sampath P; Roy AK
    Am J Emerg Med; 2014 Mar; 32(3):290.e5-6. PubMed ID: 24211287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does botulinum toxin injection in parotid glands interfere with the swallowing dynamics of Parkinson's disease patients?
    Nóbrega AC; Rodrigues B; Melo A
    Clin Neurol Neurosurg; 2009 Jun; 111(5):430-2. PubMed ID: 19181440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased Pulmonary Function During Botulinum Toxin A Therapy for Chronic Migraines in a 17-Year-Old Female.
    Oliver JD; Boesch RP; Mack KJ
    Headache; 2018 Sep; 58(8):1259-1261. PubMed ID: 30033516
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
    De Laet K; Wyndaele JJ
    Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distant OnabotulinumtoxinA Spread after Cosmetic Dosing to Facial Rhytides.
    McGuinn KP; Santa E; Saedi N
    Skinmed; 2019; 17(2):137-138. PubMed ID: 31145070
    [No Abstract]   [Full Text] [Related]  

  • 35. Uncommon foreign body reaction caused by botulinum toxin.
    Pontes HA; Pontes FS; de Oliveira GF; de Almeida HA; Guimarães DM; Cavallero FC
    J Craniofac Surg; 2012 Jul; 23(4):e303-5. PubMed ID: 22801160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esotropia following botulinum toxin type A injection for facial wrinkles.
    Lee SK; Jun HJ
    J Cosmet Laser Ther; 2018 Feb; 20(1):50-51. PubMed ID: 28682151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
    Wynn RL
    Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
    [No Abstract]   [Full Text] [Related]  

  • 39. Botulinum toxin A for children with salivary control problems.
    Montgomery J; McCusker S; Hendry J; Lumley E; Kubba H
    Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):1970-3. PubMed ID: 25242701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin in the treatment of cricopharyngeal dysphagia.
    Haapaniemi JJ; Laurikainen EA; Pulkkinen J; Marttila RJ
    Dysphagia; 2001; 16(3):171-5. PubMed ID: 11453562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.